Cargando…
The Effect of Verapamil on TXNIP Gene Expression, GLP1R mRNA, FBS, HbA1c, and Lipid Profile in T2DM Patients Receiving Metformin and Sitagliptin
INTRODUCTION: Type 2 diabetes mellitus (T2DM) is the most common type of diabetes. A decrease in the number of pancreatic beta cells is a pathological sign of diabetes, and to date there is no drug treatment that targets damage to these cells. Pancreatic beta cells have a weak antioxidant system and...
Autores principales: | Malayeri, Alireza, Zakerkish, Mehrnoosh, Ramesh, Farrokh, Galehdari, Hamid, Hemmati, Ali Asghar, Angali, Kambiz A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418290/ https://www.ncbi.nlm.nih.gov/pubmed/34480721 http://dx.doi.org/10.1007/s13300-021-01145-4 |
Ejemplares similares
-
Effect of Consumption of Whole-Wheat Breads on FBS, HbA1c, and Blood Lipids in Patients with Type 2 Diabetes
por: Nazari, Javad, et al.
Publicado: (2021) -
The effects of Anethum graveolens (dill) powder supplementation on clinical and metabolic status in patients with type 2 diabetes
por: Haidari, Fatemeh, et al.
Publicado: (2020) -
Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks
por: Hamaguchi, Tomoya, et al.
Publicado: (2011) -
The effect of berberine and fenugreek seed co-supplementation on inflammatory factor, lipid and glycemic profile in patients with type 2 diabetes mellitus: a double-blind controlled randomized clinical trial
por: Nematollahi, Shima, et al.
Publicado: (2022) -
TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients
por: Borowiec, Agnieszka Magdalena, et al.
Publicado: (2022)